Some researchers proposed the use of a multi-parametric approach—LVDD parameters (E/E’ ratio, MV DT, and LA volume) and biomolecules (GDF-15 and NT-proBNP)—in order to find the high-risk asymptomatic severe AS patients who would benefit from earlier surgery [101]. This evidence concerns the gene NPPB and aortic stenosis.